Taipei Exchange - Delayed Quote TWD

Senhwa Biosciences, Inc. (6492.TWO)

33.50
+0.30
+(0.90%)
At close: 1:30:29 PM GMT+8
Currency in TWD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
1,000
1,000
1,000
1,000
550
Cost of Revenue
530
523
448
495
227
Gross Profit
470
477
552
505
323
Operating Expense
304,864
306,668
311,663
356,620
346,639
Operating Income
-304,394
-306,191
-311,111
-356,115
-346,316
Net Non Operating Interest Income Expense
6,074
5,445
7,106
6,771
4,088
Pretax Income
-290,687
-292,464
-295,045
-348,260
-328,347
Tax Provision
1,278
1,281
1,261
1,372
910
Net Income Common Stockholders
-291,965
-293,745
-296,306
-349,632
-329,257
Diluted NI Available to Com Stockholders
-291,965
-293,745
-296,306
-349,632
-329,257
Basic EPS
-3.27
-3.29
-3.32
-3.92
-3.67
Diluted EPS
-3.27
-3.29
-3.32
-3.92
-3.67
Basic Average Shares
89,185.58
89,186
89,186
89,190
89,642
Diluted Average Shares
89,185.58
89,186
89,186
89,190
89,642
Total Expenses
305,394
307,191
312,111
357,115
346,866
Net Income from Continuing & Discontinued Operation
-291,965
-293,745
-296,306
-349,632
-329,257
Normalized Income
-291,965
-293,745
-296,306
-349,632
-329,257
Interest Income
6,699
6,108
7,641
7,315
4,614
Interest Expense
625
663
535
544
526
Net Interest Income
6,074
5,445
7,106
6,771
4,088
EBIT
-290,062
-291,801
-294,510
-347,716
-327,821
EBITDA
-277,912
-279,706
-283,785
-340,604
-321,587
Reconciled Cost of Revenue
530
523
448
495
227
Reconciled Depreciation
12,150
12,095
10,725
7,112
6,234
Net Income from Continuing Operation Net Minority Interest
-291,965
-293,745
-296,306
-349,632
-329,257
Normalized EBITDA
-277,912
-279,706
-283,785
-340,604
-321,587
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 12/4/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

3176.TWO Medigen Biotechnology Corp.
31.00
+0.65%
 
4174.TWO OBI Pharma, Inc.
34.80
-1.56%
 
4130.TWO Genovate Biotechnology Co., Ltd.
21.40
0.00%
 
6589.TWO EirGenix Inc.
62.00
-1.74%
 
4726.TWO Mycenax Biotech Inc.
39.05
-0.89%
 
6541.TW Tanvex BioPharma, Inc.
54.00
-0.37%
 
6550.TW Polaris Group
39.80
-0.50%
 
6535.TWO Lumosa Therapeutics Co., Ltd.
166.00
-5.95%
 
4162.TWO PharmaEngine, Inc.
85.20
-0.12%
 
4168.TWO GlycoNex Incorporation
25.70
+2.59%